NCT05735184 · Interventional trial
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Overall registry status Recruiting
Phase 1
Conditions AML With Mutated NPM1, Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Acute Myeloid Leukemia, in Relapse, KMT2Ar, Mixed Lineage Leukemia Gene Mutation, Myeloid Sarcoma, NPM1 Mutation, Nucleophosmin 1-mutated Acute Myeloid Leukemia, Refractory AML
Delaware Valley sites
- Hospital of the University of Pennsylvania · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory